Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Vote in favor of your Favored kind of pasta- Trump administration plan to reduce access to some student loans angers nurses, health care groups
- A top Marine shares his secrets to keeping fit at 50
- 2024's Driving Clearing Robots: Master Suggestions and Surveys
- Earth's newfound 'episodic-squishy lid' may guide our search for habitable worlds
- Fake new headlights rule steer Australian drivers astray
- Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes
- With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
- See the metal guts of a satellite in this wild X-ray view | Space photo of the day for Dec. 4, 2025
